Terpenoids as potent inhibitors of cervical cancer in pre-clinical studies

被引：0
|
作者：
Gupta, Ramesh [1 ]
Munagala, Radha [1 ]
机构：
[1] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2010年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
277
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies
    Annese, Tiziana
    Tamma, Roberto
    Ruggieri, Simona
    Ribatti, Domenico
    [J]. CANCERS, 2019, 11 (03)
  • [2] Pre-clinical studies of BRAF signalling in cancer
    Marais, R.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 44 - 45
  • [3] Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies
    Xu, Shirley
    Sharma, Umesh C.
    Tuttle, Cheyanna
    Pokharel, Saraswati
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [4] Pre-clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
    Shankar, Mohan G.
    Alex, Vijai V.
    Nisthul, Amrutha A.
    Bava, Smitha, V
    Sundaram, Sankar
    Retnakumari, Archana P.
    Chittalakkottu, Sadasivan
    Anto, Ruby John
    [J]. CELL PROLIFERATION, 2020, 53 (01)
  • [5] Pre-clinical and clinical trials: TLR inhibitors
    Vincent, Jean-Louis
    [J]. INFLAMMATION RESEARCH, 2007, 56 : S263 - S263
  • [6] Pre-clinical characterization of potent and selective next-generation RET inhibitors.
    Kolakowski, Gabrielle R.
    Anderson, Erin D.
    Ballard, Joshua A.
    Brandhuber, Barbara J.
    Condroski, Kevin R.
    Gomez, Eliana B.
    Irvin, Thomas C.
    Kumar, Manoj
    Patel, Nisha A.
    Watson, Faith D.
    Andrews, Steven W.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [7] Pre-clinical development of farnesyltransferase inhibitors
    Robert B. Lobell
    Nancy E. Kohl
    [J]. Cancer and Metastasis Reviews, 1998, 17 : 203 - 210
  • [8] Pre-clinical development of farnesyltransferase inhibitors
    Lobell, RB
    Kohl, NE
    [J]. CANCER AND METASTASIS REVIEWS, 1998, 17 (02) : 203 - 210
  • [9] PRE-CLINICAL STUDIES - DISCUSSION
    MUGGIA
    UNVERFERTH
    LEVY
    JOHNSTON
    GURTOO
    HARRISON
    [J]. SEMINARS IN ONCOLOGY, 1983, 10 (01) : 46 - 48
  • [10] Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
    Naeimzadeh, Yasaman
    Tajbakhsh, Amir
    Nemati, Mahnaz
    Fallahi, Jafar
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 978
12345